HomeCompareFGBFX vs MRK

FGBFX vs MRK: Dividend Comparison 2026

FGBFX yields 103.08% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FGBFX wins by $4.36M in total portfolio value
10 years
FGBFX
FGBFX
● Live price
103.08%
Share price
$8.27
Annual div
$8.52
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.41M
Annual income
$1,517,845.36
Full FGBFX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FGBFX vs MRK

📍 FGBFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFGBFXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FGBFX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FGBFX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FGBFX
Annual income on $10K today (after 15% tax)
$8,761.58/yr
After 10yr DRIP, annual income (after tax)
$1,290,168.56/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, FGBFX beats the other by $1,281,840.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FGBFX + MRK for your $10,000?

FGBFX: 50%MRK: 50%
100% MRK50/50100% FGBFX
Portfolio after 10yr
$2.24M
Annual income
$763,821.75/yr
Blended yield
34.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FGBFX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FGBFX buys
0
MRK buys
0
No recent congressional trades found for FGBFX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFGBFXMRK
Forward yield103.08%2.76%
Annual dividend / share$8.52$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.41M$56.8K
Annual income after 10y$1,517,845.36$9,798.13
Total dividends collected$3.95M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FGBFX vs MRK ($10,000, DRIP)

YearFGBFX PortfolioFGBFX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$21,008$10,307.74$11,206$366.19+$9.8KFGBFX
2$42,716$20,237.60$12,650$502.35+$30.1KFGBFX
3$84,164$38,457.87$14,407$694.19+$69.8KFGBFX
4$160,872$70,817.03$16,585$967.82+$144.3KFGBFX
5$298,639$126,505.59$19,342$1,363.89+$279.3KFGBFX
6$539,022$219,478.02$22,913$1,947.19+$516.1KFGBFX
7$946,979$370,226.10$27,662$2,823.89+$919.3KFGBFX
8$1,621,147$607,879.48$34,159$4,173.35+$1.59MFGBFX
9$2,707,186$972,558.41$43,337$6,308.80+$2.66MFGBFX
10$4,414,535$1,517,845.36$56,776$9,798.13+$4.36MFGBFX

FGBFX vs MRK: Complete Analysis 2026

FGBFXStock

The investment seeks a high level of current income. The fund invests in securities issued throughout the world, including securities of issuers located in emerging markets. It normally invests at least 80% of the fund&#39;s assets in debt securities of all types and repurchase agreements for those securities. The fund normally invests primarily in investment-grade debt securities.

Full FGBFX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FGBFX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FGBFX vs SCHDFGBFX vs JEPIFGBFX vs OFGBFX vs KOFGBFX vs MAINFGBFX vs JNJFGBFX vs ABBVFGBFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.